GSK peer analysis
GSK (GSK) against its competitors: price, today's move, 1-year return and market value side by side.
GSK and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMGN Amgen | $466.85 | 0.18% | 59.88% | $251.94B |
| AZN AstraZeneca | $187.53 | 0.47% | 13.88% | $289.48B |
| JNJ Johnson & Johnson | $270.34 | -1.05% | 43.00% | $657.68B |
| LLY Eli Lilly | $1,412.85 | -0.33% | 67.30% | $1.26T |
| MRK Merck | $148.98 | -0.36% | 72.67% | $368.89B |
| NVO Novo Nordisk | $40.56 | 1.40% | -18.94% | $176.43B |
| NVS Novartis | $161.49 | 0.44% | 31.71% | $303.67B |
| PFE Pfizer | $30.91 | 1.29% | 27.27% | $173.95B |
| SNY Sanofi | $45.37 | 2.32% | -10.93% | $106.24B |
| GSK GSK | $49.11 | -0.81% | 4.62% | $99.19B |
- GSK's peers: AMGN (Amgen), AZN (AstraZeneca), JNJ (Johnson & Johnson), LLY (Eli Lilly), MRK (Merck), NVO (Novo Nordisk), NVS (Novartis), PFE (Pfizer).
Updated 2026-11-02 19:54 UTC